The multifaceted response of the fruitfly Drosophila melanogaster to infection by a wide range of microbes is complex and remarkably efficient. Its most prominent aspect is the immune-inducible expression of a set of potent antimicrobial peptides. Genetic analysis of the regulation of the genes encoding these peptides has led to the identification of the receptor Toll as an essential component of the fly's host defense system. In addition, these studies have revealed that the response to Gramnegative bacterial infections involves Toll-independent mechanisms, and that the sensing of infection involves two structurally distinct sets of molecules -the PGRPs and the GNBPs/βGRPs.
INTRODUCTION
Like higher insects, fruit-flies defend themselves against infectious micro-organisms by a combination of three mechanisms. First, as in other animals, blood cells can phagocytose invading microbes and alert other tissues about their presence. [1] [2] [3] Second, proteolytic cascades are activated and lead to hemolymph coagulation, thus limiting the spread of the infection, and to synthesis of melanin and cytotoxic reactive oxygen species by the enzyme phenoloxidase, which affect invading microorganisms. 4, 5 Third, a strong humoral response, characterized by the rapid and massive secretion of a diverse set of broad spectrum antimicrobial peptides, is activated. These peptide antibiotics are predominantly expressed in the fat body, the functional equivalent of the mammalian liver. The latter two mechanisms are well suited for insects, whose organs bathe in the hemolymph. The production of antimicrobial peptides has been the subject of intense scrutiny using biochemistry and genetics in the past 15 years, and is the best understood aspect of the Drosophila host-defense system today. 6 The Drosophila humoral response
Seven distinct families of antimicrobial peptides have been identified. They are structurally diverse and, as their mammalian counterparts, are mostly small in size (5 kDa), cationic and predominantly membrane active. Their activity spectra are directed against filamentous fungi (drosomycins, metchnikowin), Gram-positive (defensin) or Gram-negative (diptericins, attacins, cecropins, drosocin) bacteria. The combined activities of these peptides largely contribute to the clearing of invading micro-organisms in the hemolymph. 7, 8 An interesting feature of the genes encoding these peptides pertains to the sequences of their promoters, which are characterized by the presence of nucleotide motifs similar to binding sites for the mammalian factor NF-κB. Mutations in these sequences in the promoter of the Cecropin and Diptericin genes in the early 1990s revealed that they were functionally essential for the immune-inducibility of the genes. 9 Despite the presence of similar motifs related to NF-κB binding sites in the promoters of all antimicrobial peptide genes, genetic analysis revealed that their transcription was controlled by two distinct signal transduction pathways, aimed at specific NF-κB like molecules ( Fig. 1 ). The antifungal peptide gene Drosomycin is essentially controlled by the DIF transcription factor activated by the Toll pathway, whereas Diptericin and other antibacterial peptide genes are mostly regulated by another NF-κB related factor named Relish, activated by the immune deficiency (IMD) pathway. 6, 10, 11 Toll pathway mutants exhibit enhanced susceptibility to fungal infections, but also to most Gram-positive bacterial infections. 12 The Toll pathway mediates immune inducibility of dozens of genes in addition to Drosomycin, which probably contribute to the resistance to infection (Fig. 2 ). 13, 14 Upon activation, the Toll receptor activates a cytoplasmic complex composed of DmMyD88, the death domain protein Tube, and the IRAK4 homologue Pelle. This leads by poorly characterized mechanisms to the phosphorylation and degradation of the cytoplasmic IκB homologue Cactus, thus allowing nuclear translocation of DIF. On the other hand, IMD pathway mutants are mostly susceptible to Gram-negative bacterial infections. IMD has been shown to encode a cytoplasmic protein containing a death domain most closely related to that of RIP, an essential signal transducer of the TNF pathway in mammalian cells. IMD regulates activity of Relish through the intermediates of the homologue of the mammalian factor FADD, and the caspase-8 homologue DREDD, which is thought to cleave Relish, thus separating the active C-terminus which contains the NF-κB domain from the inhibitory N-terminus which harbours several IκB-like ankyrin repeats. Activation of Relish also involves phosphorylation of the transcription factor by an IKKβ/IKKγ complex homologue encoded by the products of the genes kenny and ird5. An homologue of the TAK1/TAB2 complex is also involved in the activation of Relish (reviewed elsewhere 6, 11, 15 and Jung et al., submitted). Overall, the most striking aspect of the IMD pathway is the presence of many molecules structurally and functionally related to components of the TNF pathway in mammals.
In summary, the potent humoral defense system of Drosophila involves at least two pathways, one which is dependent on the Toll receptor and regulates DIF, and one which is independent of the Toll receptor and regulates another member of the NF-κB family, Relish ( Fig. 1 ).
Toll receptors in Drosophila
Although Drosophila Toll, like mammalian TLRs, is a critical receptor of the innate immune system, it does not function as a pattern recognition receptor. In fact, genetic evidence indicates that the products of other Drosophila genes act upstream of Toll. One of these genes is spaetzle, which encodes a cystein-knot growth factor distantly related to neurotrophins, and which is required for normal immune response to fungi and most Gram-positive bacterial infections, like Toll. 16 The product of this gene is expressed as an inactive precursor, which is activated by proteolytic cleavage. The biological meaning of this cleavage has recently been clarified, as it was shown using recombinant forms of the precursor and cleaved protein that only the proteolytically processed version of the molecule was able to bind to Toll and trigger signaling. 17 The large prodomain of Spaetzle, therefore, appears to prevent binding of the factor to its receptor in the absence of immune challenge. Independent genetic data nicely complement these findings: indeed, (i) flies containing mutations in the necrotic gene, which encodes a serine protease inhibitor, constitutively express Drosomycin, indicating that a tightly regulated serine protease regulates cleavage of Spaetzle and activation of the Toll pathway; 18 and (ii) flies with mutations in the gene persephone (psh), which encodes a serine protease, do not activate the Toll pathway in response to fungal infections. 19 Hence, Toll in Drosophila functions like a receptor for the neurotrophin-related cytokine Spaetzle. Interestingly, while spaetzle-related genes appear to be absent from the mammalian genomes, 5 related genes (spaetzle-2 to spaetzle-6) are present in the Drosophila genome, and could encode ligands for the other Drosophila Toll receptors. 20 The early results on TLRs in mammals which pointed to TLR4 as a receptor for lipopolysaccharides (LPSs), and TLR2 as a receptor for peptidoglycan (PGN), raised the question whether a Toll-related receptor may be involved in the IMD-dependent response to Gram-negative bacterial infections. Indeed, the Drosophila genome encodes a total of nine Toll receptors. However, none of them can activate the IMD-regulated promoters of the antibacterial peptides genes. Surprisingly, two members of the family (Toll-5 and Toll-9), in addition to Toll, can activate the Drosomycin promoter. [21] [22] [23] [24] The biological significance of this finding is, however, unclear as immune inducibility of the Drosomycin promoter by fungal or Gram-positive bacterial infection is completely abolished in the absence of Toll. 12, 16 The phenotype of DmMyD88 mutant flies, which respond like wild-type flies to Gram-negative infections, confirmed the existence of differences between mammals and insects, and did not support the hypothesis that a Toll-related receptor was involved in the IMD pathway. 25 14 These results indicate that two subfamilies can be defined amongst Drosophila Tolls, the first composed of Toll, Toll-5 and Toll-9 which can, presumably through DmMyD88, activate the drosomycin promoter, and the second composed of Toll-2 (also called 18-wheeler), -3, -4, -6, -7, and -8, which regulate other targets, in a MyD88-independent manner. The identity of these targets remains to be defined, but may be related to development. One striking property of Drosophila Tolls is that they are most highly expressed at the critical developmental stages of embryogenesis and metamorphosis. 21 A detailed analysis of the expression patterns of the Tolls in the embryo revealed that they are expressed in a timely and spatially regulated manner in a diverse set of tissues and organs, including the epidermis (Toll-8), the muscles (Toll and Toll-5), the circulatory system (Toll and Toll-5), the respiratory tract (Toll-7), the digestive tract (Toll, Toll-5, Toll-7, Toll-8), the nervous system (Toll-6 and Toll-7) and the hematopoietic compartment (Toll, Toll-4 and Toll-9). 26 These data suggest that most Tolls in Drosophila may carry developmental functions, as already demonstrated for Toll, 18wheeler (Toll-2) and Toll-8. [27] [28] [29] [30] [31] In summary, there is no evidence to date that Toll receptors carry functions related to immune defense in flies, with the exception of the founding member of the family Toll. However, Toll functions like a cytokine receptor: recognition of microbial patterns occurs upstream of Toll, and involves different families of pattern recognition receptors (PRRs), the PGRPs and the GNBPs.
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Pattern recognition receptors in Drosophila
The Toll pathway is activated by both fungal and Grampositive bacterial infections, indicating that either these quite different types of micro-organisms share microbial patterns that are recognized upstream of Toll, or that there is a branching point upstream of Spaetzle in the pathway, with one branch activated by fungi, and the other by most Grampositive bacteria. Discovery and characterization of the semmelweiss (seml) mutation resolved this issue. 32 Indeed, seml mutant flies are defective for induction of Drosomycin in response to Gram-positive bacteria, but not to fungi. Conversely, the persephone mutation mentioned above affects induction of the Toll pathway by fungi, but not by Gram-positive, providing independent genetic evidence for a branching point in the pathway upstream of Spaetzle. 19 The gene seml was cloned and found to encode a secreted member of the peptidoglycan (PGN) recognition protein (PGRP) family, PGRP-SA, which had previously been shown to bind the lysine-type PGN (Lys-PGN) characteristic of most Gram-positive bacteria. 32, 33 The Drosophila genome encodes 13 members of the PGRP family, divided in two subfamilies based on their size (20 kDa for the S or short ones; 30-90 kDa for the L or long ones). Soon after the initial report of the importance of the PGRP-SA in activation of the Toll pathway, independent genetic approaches led to the identification of another member of the PGRP family, PGRP-LC, as an essential component of the IMD pathway. [34] [35] [36] Though surprising at first, the identification of a member of the PGRP family as a receptor for the IMD pathway reflects the nature of the Gram-negative molecule that activates the IMD pathway in flies. Indeed, LPS appears to be a poor inducer of the immune response in flies, and has very limited effects, if any, on the induction of antimicrobial peptide genes when injected into flies. 37, 38 By contrast, injection of the diaminopimelic acid-type PGN (DAP-PGN), predominantly found in the inner cell wall of Gram-negative bacteria into flies leads to induction of the Diptericin gene in a PGRP-LC dependent manner. Lys-PGN, which is present on the cell wall of most Gram-positive bacteria, does not induce Diptericin expression, but induces the Toll pathway in a PGRP-SA dependent manner. 38 These results indicate that the Toll and IMD pathways are activated by receptors of the PGRP family which can discriminate between the PGN types of the invading bacteria: Lys-PGN containing bacteria activate the Toll pathway, whereas DAP-PGN containing bacteria activate the IMD pathway.
Like some TLRs in mammals, which associate with co-receptors (e.g. CD14, MD2 for TLR4; TLR1, TLR6, dectin for TLR2), PGRPs interact with other molecules to form receptor complexes. For example, PGRP-LC mutant flies exhibit milder phenotypes than most other mutants of the IMD pathway, indicating that other receptors can to some extent bypass PGRP-LC. 34, 35 In addition, it was shown that overexpression in transgenic larvae of another long-form PGRP interacting with DAP-PGN, PGRP-LE, leads to activation of the IMD pathway, suggesting that PGRP-LC and PGRP-LE may function in a similar complex. 39 With regard to PGRP-SA, the mutation osiris, which affects a gene encoding another type of pattern recognition receptor, Gram-negative binding protein (GNBP) 1, was found to have the same phenotype as the seml mutation. 40 GNBPs (also called β-glucan recognition proteins or βGRPs) are 50 kDa proteins with an N-terminal β-(1,3)-glucan binding domain, and a C-terminal β-glucanase-like domain. 41, 42 Thus, the presence of both PGRP-SA and GNBP1 appears to be required in the hemolymph to recognize infection by Lys-PGN containing bacteria, and trigger signaling. Interestingly, another member of the GNBP family, GNBP3, is encoded by the gene hades, which is required for activation of the Toll pathway by fungi (D.F., unpublished observations).
CONCLUSIONS
The emerging global picture of the mechanisms by which Drosophila senses infection points to differences between insects and mammals. In particular, the pattern recognition receptors are different, and the use of Toll receptors as PRRs appears at this stage restricted to vertebrates. Drosophila PRRs known to date belong to two different structural families -the PGRPs and the GNBP/βGRPs. A major challenge in the coming years will be to understand how these PRRs specifically interact with microbial molecular patterns, and how this interaction leads to signal transduction.
